Education
About Us
Working with TipRanks
Follow Us
BAMV - ETF AI Analysis
Top Page
Brookstone Value Stock ETF (BAMV)
Rating:70Outperform
Price Target:―
Positive Factors
Strong Top Holdings
Several key positions, such as AMD and Johnson & Johnson, have delivered strong year-to-date performance, supporting the fund’s overall returns.
Sector Diversification
The ETF spreads its investments across multiple sectors, including Technology, Health Care, and Industrials, reducing reliance on any single industry.
Steady Performance
The ETF has shown consistent positive returns over the year-to-date, one-month, and three-month periods, indicating solid momentum.
Negative Factors
High Expense Ratio
The ETF charges a relatively high expense ratio compared to many other funds, which could eat into investor returns over time.
Over-Concentration in U.S. Market
With over 99% exposure to U.S. companies, the fund lacks geographic diversification and may be vulnerable to domestic market downturns.
Mixed Holding Performance
While some holdings have performed well, others like Lennar have lagged, potentially dragging on overall returns.
BAMV vs. SPDR S&P 500 ETF (SPY)
AUM97.28M
RegionNorth America
Expense Ratio0.91%
Beta0.70
IssuerBrookstone
Inception DateSep 27, 2023
Dividend Yield1.18%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume13,055
30 Day Avg. Volume17,626
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
37.65Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering30
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BAMV Summary
The Brookstone Value Stock ETF (BAMV) is an investment fund that focuses on value stocks, which are companies believed to be undervalued by the market but have strong fundamentals and growth potential. It includes a mix of sectors like technology, healthcare, and financials, with well-known companies such as Advanced Micro Devices (AMD) and Johnson & Johnson (JNJ) among its top holdings. Investors might consider BAMV for diversification and the opportunity to invest in stocks that could grow as their true value is recognized. However, new investors should be aware that the ETF’s performance depends on the market’s ability to correctly value these stocks, which can fluctuate over time.
How much will it cost me?The Brookstone Value Stock ETF (BAMV) has an expense ratio of 0.91%, meaning you’ll pay $9.10 per year for every $1,000 invested. This is higher than average because it is actively managed, which typically involves more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?The Brookstone Value Stock ETF (BAMV) could benefit from positive trends in the technology and healthcare sectors, which make up a significant portion of its holdings, as well as potential growth in undervalued stocks during economic recoveries. However, rising interest rates or economic slowdowns could negatively impact its financial and industrial sector exposure, while regulatory changes in North America might affect its top holdings like AMD and Johnson & Johnson. Diversification across sectors helps mitigate some risks, but sector-specific challenges remain a key factor to watch.
BAMV Top 10 Holdings
The Brookstone Value Stock ETF (BAMV) leans heavily on technology and healthcare, with names like AMD and Johnson & Johnson driving much of the action. AMD is rising on AI and data center growth, while Johnson & Johnson’s steady performance reflects strong product launches and strategic focus. Merck is showing mixed signals, with attractive valuation but lagging year-to-date. On the flip side, Lockheed Martin and Lennar are dragging the fund, with declining margins and market pressures weighing on their outlook. Overall, the ETF’s U.S.-centric portfolio balances growth opportunities with value-driven stability.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Merck & Company | 4.12% | $4.05M | $260.19B | 3.14% | 76 Outperform | |
| Advanced Micro Devices | 4.10% | $4.03M | $354.15B | 58.58% | 74 Outperform | |
| Thermo Fisher | 4.05% | $3.98M | $221.98B | 11.56% | 73 Outperform | |
| Johnson & Johnson | 4.03% | $3.96M | $498.53B | 33.49% | 78 Outperform | |
| Lennar | 3.78% | $3.72M | $33.24B | -24.71% | 64 Neutral | |
| Bank of America | 3.67% | $3.60M | $391.78B | 12.92% | 70 Outperform | |
| Bristol-Myers Squibb | 3.64% | $3.57M | $100.16B | -16.92% | 69 Neutral | |
| Qualcomm | 3.63% | $3.57M | $180.02B | 6.03% | 80 Outperform | |
| General Dynamics | 3.63% | $3.56M | $92.28B | 20.29% | 80 Outperform | |
| Fortive | 3.56% | $3.50M | $16.99B | -32.58% | 72 Outperform |
BAMV Technical Analysis
Positive
―
Price Trends
32.04
Positive
31.97
Positive
31.29
Positive
Market Momentum
-0.09
Negative
54.84
Neutral
79.07
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BAMV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 31.89, equal to the 50-day MA of 32.04, and equal to the 200-day MA of 31.29, indicating a bullish trend. The MACD of -0.09 indicates Negative momentum. The RSI at 54.84 is Neutral, neither overbought nor oversold. The STOCH value of 79.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BAMV.
BAMV Peer Comparison
Comparison Results
Performance Comparison
BAMV
Brookstone Value Stock ETF
32.24
0.31
0.97%
RVER
Trenchless Fund ETF
―
―
―
YALL
God Bless America ETF
―
―
―
TCV
Towle Value ETF
―
―
―
GMOV
GMO US Value ETF
―
―
―
CVAR
Cultivar ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents